New You Performance
| NWYUDelisted Stock | USD 0.0003 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and New You are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days New You has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, New You is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 1125.00 |
New |
New You Relative Risk vs. Return Landscape
If you would invest 0.03 in New You on September 5, 2024 and sell it today you would earn a total of 0.00 from holding New You or generate 0.0% return on investment over 90 days. New You is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than New, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
New You Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for New You's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as New You, and traders can use it to determine the average amount a New You's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NWYU |
Based on monthly moving average New You is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of New You by adding New You to a well-diversified portfolio.
New You Fundamentals Growth
New OTC Stock prices reflect investors' perceptions of the future prospects and financial health of New You, and New You fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on New OTC Stock performance.
| Return On Asset | -2.64 | |||
| Operating Margin | (2.67) % | |||
| Current Valuation | 1.46 M | |||
| Shares Outstanding | 49.95 M | |||
| Price To Sales | 0.01 X | |||
| Revenue | 2.01 M | |||
| EBITDA | (4.24 M) | |||
| Cash And Equivalents | 14.58 K | |||
| Total Debt | 128.88 K | |||
| Book Value Per Share | (0.24) X | |||
| Cash Flow From Operations | (486.37 K) | |||
| Earnings Per Share | (0.34) X | |||
| Total Asset | 197.09 K | |||
About New You Performance
Assessing New You's fundamental ratios provides investors with valuable insights into New You's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the New You is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
New You, Inc., through its subsidiary, New You LLC, develops and markets cannabidiol hemp oil-based products. The company markets and sells its products through multi-level marketing and direct sales force to independent business owners. New You operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.Things to note about New You performance evaluation
Checking the ongoing alerts about New You for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for New You help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| New You is not yet fully synchronised with the market data | |
| New You has some characteristics of a very speculative penny stock | |
| New You has a very high chance of going through financial distress in the upcoming years | |
| New You currently holds 128.88 K in liabilities. New You has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist New You until it has trouble settling it off, either with new capital or with free cash flow. So, New You's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like New You sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for New to invest in growth at high rates of return. When we think about New You's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.01 M. Net Loss for the year was (5.05 M) with profit before overhead, payroll, taxes, and interest of 1.72 M. | |
| New You currently holds about 14.58 K in cash with (486.37 K) of positive cash flow from operations. | |
| Roughly 52.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing New You's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether New You's stock is overvalued or undervalued compared to its peers.
- Examining New You's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating New You's management team can have a significant impact on its success or failure. Reviewing the track record and experience of New You's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of New You's otc stock. These opinions can provide insight into New You's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in New OTC Stock
If you are still planning to invest in New You check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the New You's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |